Division of Hematology and Oncology
Breast Cancer Risk Reduction, Breast Cancer Treatment, Head and Neck Cancer
University of Tennessee, Memphis, 1983
Internal Medicine, University of Massachusetts in Worchester Memorial Hospital, Massachusetts, 1986
Hematology/Oncology, Duke University Medical Center, North Carolina, 1989
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
Pannell TA, Panella TJ, Zaretzki RL.
The prognostic impact of determining treatment plans based on discordant metastatic tumor receptors on relapse. American Journal of Hematology / Oncology. 2016;12(9):14-20.
The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290
Copyright © 2019